Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients.

[1]  A. Milito,et al.  Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  Thomas F. Smith,et al.  Human β-Herpesvirus Interactions in Solid Organ Transplant Recipients , 2001 .

[3]  C. Payá,et al.  Human herpesvirus‐6 and ‐7 in transplantation , 2001, Reviews in medical virology.

[4]  A. Limaye,et al.  Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants , 2000, The Lancet.

[5]  M. Schnitzler,et al.  The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. , 2000, The Journal of infectious diseases.

[6]  R. Rubin,et al.  Prevention dof recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir , 2000 .

[7]  I. Sia,et al.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. , 2000, Clinical microbiology reviews.

[8]  T. Tsukazaki,et al.  Comparison of antiviral compounds against human herpesvirus 6 and 7. , 1998, Antiviral research.

[9]  F. Baldanti,et al.  Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. , 1998, Transplantation.

[10]  N. Ahsan,et al.  Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients. , 1997, Clinical transplantation.

[11]  Y. Lau,et al.  Human herpesvirus‐6 and human herpesvirus‐7 infections in bone marrow transplant recipients , 1997, Journal of medical virology.

[12]  C. Taylor,et al.  “Cytomegalovirus disease” in renal allograft recipients: Is human herpesvirus 7 a co‐factor for disease progression? , 1996, Journal of medical virology.

[13]  B. Weill,et al.  Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  M. Ho.  Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. , 1991, Transplantation proceedings.